|
|
| Line 1: |
Line 1: |
| {{drugbox
| |
| | IUPAC_name = 4-(aminomethyl)cyclohexane-1-carboxylic acid
| |
| | image = Tranexamic acid.svg
| |
| | width = 75
| |
| | CAS_number = 1197-18-8
| |
| | ATC_prefix = B02
| |
| | ATC_suffix = AA02
| |
| | ATC_supplemental =
| |
| | PubChem = 5526
| |
| | DrugBank = APRD01270
| |
| | C = 8 | H = 15 | N = 1 | O = 2
| |
| | molecular_weight = 157.21 g/mol
| |
| | bioavailability = 34%
| |
| | protein_bound =
| |
| | metabolism =
| |
| | elimination_half-life = 3.1 hours
| |
| | pregnancy_category = B
| |
| | legal_status =
| |
| | routes_of_administration = Injection and oral
| |
| }}
| |
| {{SI}}
| |
| {{CMG}}
| |
|
| |
|
|
| |
|
| |
| '''Tranexamic acid''' (commonly marketed as '''Cyklokapron''' in the U.S. and as '''Transamin''' in Asia) is often prescribed for excessive bleeding. It is an [[antifibrinolytic]] that competitively inhibits the activation of [[plasminogen]] to [[plasmin]], a molecule responsible for the degradation of [[fibrin]]. Fibrin is the basic framework for the formation of a blood clot in hemostasis. It has roughly 8 times the [[antifibrinolytic]] activity of an older analogue, ε-aminoacaproic acid.
| |
|
| |
| ==Therapeutic uses==
| |
|
| |
| ===Menstrual bleeding===
| |
|
| |
| Tranexamic acid (cyklokapron, transamin) is a synthetic derivative of the amino acid lysine. It exerts its antifibrinolytic effect through the reversible blockade of lysine binding sites on plasminogen molecules <ref>[http://www.drugs.com/cons/Tranexamic_Acid.html Antifibrinolytic agents at drugs.com]</ref>. It inhibits endometrial plasminogen activator and thus prevents fibrinolysis and the breakdown of clot. Side effects are uncommon. While prolonged treatment may heighten the risk of an increased thrombotic tendency, such as deep vein thrombosis, large scale studies reveal that the incidence of thrombosis in women treated by tranexamic acid is no different from the spontaneous incidence of thrombosis in women.
| |
|
| |
| Tranexamic acid is used as firstline nonhormonal treatment of dysfunctional uterine bleeding, and heavy bleeding associated with uterine fibroids. A recent study <ref>[http://www.ajsp.com/pt/re/ajsp/abstract.00000478-200708000-00012.htm;jsessionid=GxsctZ0w9f1dpFg2G2yr2PSDfNznZSZqgcg1v5Mphph67nCnGsf2!1683421839!181195628!8091!-1 The American Journal of Surgical Pathology]</ref> showed that patients treated with tranexamic acid are more likely to develop thrombosis and necrosis in their fibroids, and may result in pain and fever. Moreover, the histological appearance of the necrosis in these drug-related fibroids may be mistaken for smooth muscle tumors of uncertain malignant potential.
| |
|
| |
| ===Haemophilia===
| |
| Tranexamic acid is also useful in the treatment of bleeding as a second line treatment next to factor VIII in [[haemophilia]] patients (i.e. Tooth extraction in [[haemophilia]] patients.)
| |
|
| |
| ===Angioedema===
| |
| In acquired [[angioedema]] types I and II and non-histaminergic angioedema, antifibrinolytics such as tranexamic acid or ε-aminocaproic acid may be effective.
| |
|
| |
| ===Cardiac surgery===
| |
| Tranexamic acid is used in cardiac surgery, e.g. [[coronary artery bypass surgery]], to prevent excessive blood loss.
| |
|
| |
| ===Orthopedic Surgery===
| |
| Tranexamic acid is used in orthopedic surgery to reduce bloodloss. It is of proven value in clearing the field of surgery and reducing per and postoperative blood loss. Drain and number of transfusion is reduced. However the hidden blood loss is not reduced. Still it is becoming an important tool in the anaesthetist's arsenal. It is commonly used in joint replacement surgery.
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |
|
| |
| ==Additional Resources==
| |
|
| |
| * [http://www.medicine.ox.ac.uk/ohc/tranexam.htm Tranexamic acid] (Dr. P.L.F. Giangrande, Oxford Haemophilia Centre)
| |
| * [http://www.patient.co.uk/showdoc/30002117/ Tranexamic acid] (UK patient information leaflet)
| |
| * [http://www.hereditaryangioedema.com/angiotable.html Types of Angioedema and treatments] (Hereditary Angioedema Association)
| |
|
| |
| {{Antihemorrhagics}}
| |
|
| |
|
| |
| [[Category:Antifibrinolytics]]
| |
| [[Category:Hematology]]
| |
|
| |
| [[de:Tranexamsäure]]
| |
| [[es:Ácido tranexámico]]
| |
| [[fr:Acide tranexamique]]
| |
| [[it:Acido tranexamico]]
| |
| [[ja:トラネキサム酸]]
| |
| [[pl:Kwas traneksamowy]]
| |
|
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |